Jade Biosciences Dividends

JBIO Stock   14.39  1.61  10.06%   
As of the 6th of February 2026, Dividend Paid And Capex Coverage Ratio is likely to drop to -482.81. Jade Biosciences' past performance could be the main factor of why investors trade Jade Biosciences stock today. Investors should clearly understand every aspect of the Jade Biosciences dividend schedule, including its future sustainability, and how it might impact an overall investment strategy. This tool is helpful to digest Jade Biosciences' dividend schedule and payout information. Jade Biosciences dividends can also provide a clue to the current valuation of Jade Biosciences.
Last ReportedProjected for Next Year
Dividend Paid And Capex Coverage Ratio(459.82)(482.81)
One of the primary advantages of investing in dividend-paying companies such as Jade Biosciences is that dividends usually grow steadily over time. As a result, well-established companies that pay dividends typically increase their dividend payouts yearly, which many long-term traders find attractive.
Investing in stocks that pay dividends is one of many strategies that are good for long-term investments. Ex-dividend dates are significant because investors in Jade Biosciences must own a stock before its ex-dividend date to receive its next dividend.

Jade Biosciences Expected Dividend Income Per Share

Dividend payment represents part of Jade Biosciences' profit that is distributed to its stockholders. It is considered income for that tax year rather than a capital gain. In other words, a dividend is a prize given to shareholders for investing in Jade Biosciences. Jade Biosciences' board of directors can pay out dividends at a planned frequency, such as monthly or quarterly.
$0.58
Bottom Scenario
0.8
$1.02
Top Scenario
One Year
Jade Biosciences expected dividend income per share adjusted for ongoing price standard deviation

Jade Biosciences Past Distributions to stockholders

Will Biotechnology sector continue expanding? Could Jade diversify its offerings? Factors like these will boost the valuation of Jade Biosciences. Expected growth trajectory for Jade significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Jade Biosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Jade Biosciences's market price often diverges from its book value, the accounting figure shown on Jade's balance sheet. Smart investors calculate Jade Biosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Jade Biosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Jade Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Jade Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Jade Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Compare Dividends Across Peers

Specify up to 10 symbols: